| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2873335 | The Annals of Thoracic Surgery | 2014 | 7 Pages |
Abstract
The present study indicates that LVI is a strong prognostic indicator for poor outcome for patients with surgically managed stage I lung cancer. Future prospective lung cancer trials with well-defined methods for evaluating LVI are necessary to validate these results.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nathan M. DO, Carrie MPH, Eric MD, Leah MD, Beth PhD, PharmD, Mark K. MD,